OES
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98590242
- Registration number
- 7989726
- Mark type
- Stylized text
- Filed
- 07 Jun 2024
- Published for opposition
- 02 Sept 2025
- Registered
- 21 Oct 2025
- Attorney of record
- Janet F. Satterthwaite
Goods and services
- Class 001 — Chemicals: Reagents for use in nucleic acids sequencing in scientific research; Enzymes for use in nucleic acids sequencing in scientific research; Reagents for use in biological processing, namely, reagents for use in scientific apparatus for biological analysis; Biological preparations for enzymatic reactions laboratory research, gene identification, and molecule sequencing identification, other than for medical or veterinary purposes; Stem cells other than for medical or veterinary purposes; Biological tissue cultures other than for medical or veterinary purposes; Diagnostic reagents for clinical laboratory use; Diagnostic enzymes for use in nucleic acids sequencing for clinical laboratory purposes
- Class 005 — Pharmaceuticals: Medical reagents for use in nucleic acids sequencing for clinical and medical diagnostic purposes; Enzymes for use in nucleic acids sequencing for clinical and diagnostic medical purposes; Biological preparations for analysis of cancer progression, treatment effectiveness, and metastasis risk for the treatment of cancer; Biomarker diagnostic reagents for medical purposes; Test paper being reagent paper for medical purposes; Chemical reagent for medical purposes, stem cells for medical purposes; Enzymes for medical purposes; Enzyme preparations for medical purposes; Reagents for use in biological processing, namely, medical reagents for processing human liquid biopsy in the medical field
- Class 009 — Scientific and electric apparatus: Nucleic acid sequencers used for analyzing nucleic acids in scientific research; Imaging devices other than x-ray apparatus used for analyzing nucleic acid sequence in scientific research; Biochip readers for research or scientific purposes; Biochip testing machines for research or scientific purposes; Biochips for research and scientific purposes; DNA chips; Laboratory apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and equipment for making and screening molecular arrays; Scientific instruments for genetic analysis; Downloadable computer software for scientific analysis of genetic sequences; Semiconductor chips or silicon dioxide chips having multi-well arrays that are used for genetic sequencing and biochemical analysis in scientific, laboratory, and medical research; Silicon dioxide chips having multi-well arrays that are used for genetic sequencing and biochemical analysis in scientific, laboratory, and medical research
- Class 010 — Medical apparatus: Clinical and medical devices, namely, nucleic acid sequencers and non-X-ray biological imaging devices used for analyzing nucleic acids, genetic sequencing and genetic mutation detection for use in the medical treatment of cancer; Diagnostic apparatus for DNA and RNA exams for medical purposes
Owner
- Personal Genomics Taiwan, Inc., Zhubei, Hsinchu, TW
- Personal Genomics Taiwan, Inc., Zhubei, Hsinchu, TW
- Personal Genomics Taiwan, Inc., Zhubei, Hsinchu, TW
Prosecution history
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Sept 2025 — PUBLISHED FOR OPPOSITION
- 27 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Aug 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 17 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Apr 2025 — NON-FINAL ACTION E-MAILED
- 07 Apr 2025 — NON-FINAL ACTION WRITTEN
- 07 Mar 2025 — ASSIGNED TO EXAMINER
- 06 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED